154 related articles for article (PubMed ID: 33380674)
1. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer.
Sakin A; Samanci NS; Secmeler S; Arici S; Can O; Yasar N; Geredeli C; Demir C; Cihan S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S176-S182. PubMed ID: 33380674
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis.
Xu Y; Li C; Zheng CZ; Zhang YQ; Guo TA; Liu FQ; Xu Y
BMC Cancer; 2021 Jan; 21(1):45. PubMed ID: 33422027
[TBL] [Abstract][Full Text] [Related]
3. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.
Jiang K; Zhu Y; Liu Y; Ye Y; Xie Q; Yang X; Wang S
Tumour Biol; 2014 Nov; 35(11):11685-90. PubMed ID: 25139098
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
Uratani R; Toiyama Y; Shimura T; Mori K; Fujikawa H; Hiro J; Ohi M; Inoue Y; Tanaka K; Araki T; Mohri Y; Kusunoki M
Anticancer Res; 2015 Oct; 35(10):5639-48. PubMed ID: 26408737
[TBL] [Abstract][Full Text] [Related]
6. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
[TBL] [Abstract][Full Text] [Related]
7. Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
Cantini L; Pistelli M; Merloni F; Fontana A; Bertolini I; De Angelis C; Bastianelli L; Della Mora A; Santinelli A; Savini A; Maccaroni E; Diodati L; Falcone A; Berardi R
Clin Breast Cancer; 2020 Feb; 20(1):e89-e98. PubMed ID: 31378534
[TBL] [Abstract][Full Text] [Related]
8. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
[TBL] [Abstract][Full Text] [Related]
9. Association of body mass index and smoking on outcome of Chinese patients with colorectal cancer.
Liu D; Li Q; Yang Z; Hu X; Qian W; Du Y; Liu B
World J Surg Oncol; 2013 Oct; 11():271. PubMed ID: 24119458
[TBL] [Abstract][Full Text] [Related]
10. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
[TBL] [Abstract][Full Text] [Related]
11. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer.
Wong GG; Ha V; Chu MP; Dersch-Mills D; Ghosh S; Chambers CR; Sawyer MB
Clin Colorectal Cancer; 2019 Mar; 18(1):72-79. PubMed ID: 30551953
[TBL] [Abstract][Full Text] [Related]
12. Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer.
Liu XY; Kang B; Cheng YX; Yuan C; Tao W; Zhang B; Wei ZQ; Peng D
BMC Cancer; 2022 Jun; 22(1):596. PubMed ID: 35641911
[TBL] [Abstract][Full Text] [Related]
13. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
Seddik Y; Brahmi SA; Afqir S
Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Chinese materia medica combined chemotherapy on the survivals of stage II and III colorectal cancer].
Lu XM; Zheng J; Zhu YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1166-70. PubMed ID: 23185751
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.
Kroenke CH; Neugebauer R; Meyerhardt J; Prado CM; Weltzien E; Kwan ML; Xiao J; Caan BJ
JAMA Oncol; 2016 Sep; 2(9):1137-45. PubMed ID: 27196302
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer.
Walter V; Jansen L; Hoffmeister M; Ulrich A; Roth W; Bläker H; Chang-Claude J; Brenner H
Am J Clin Nutr; 2016 Oct; 104(4):1110-1120. PubMed ID: 27581471
[TBL] [Abstract][Full Text] [Related]
18. The association between body mass index and postoperative complications, 30-day mortality and long-term survival in Dutch patients with colorectal cancer.
Arkenbosch JHC; van Erning FN; Rutten HJ; Zimmerman D; de Wilt JHW; Beijer S
Eur J Surg Oncol; 2019 Feb; 45(2):160-166. PubMed ID: 30712552
[TBL] [Abstract][Full Text] [Related]
19. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
[TBL] [Abstract][Full Text] [Related]
20. Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Dec; 18(4):e385-e393. PubMed ID: 31378656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
